Recombinant Human ADSL/Adenylosuccinate Lyase Protein，His

Adenylosuccinate lyase (ADSL) is a crucial enzyme involved in the purine nucleotide synthesis pathway, catalyzing the conversion of adenylosuccinate to adenine monophosphate (AMP) and fumarate. Mutations in the ADSL gene can lead to a rare but severe genetic disorder known as adenylosuccinate lyase deficiency, which is characterized by a range of neurological symptoms, intellectual disability, and developmental delays. The exploration of ADSL has garnered significant attention in biochemistry and molecular biology, particularly regarding the mechanisms underlying its enzymatic function and the repercussions of genetic mutations. The recombinant production of ADSL protein enables researchers to study its structure and function in depth, assess the effects of specific mutations, and explore potential therapeutic interventions. Characterizing the enzyme's kinetics and identifying inhibitors could yield insights into drug design for related metabolic disorders. Understanding ADSL not only sheds light on fundamental biochemical pathways but also has implications for the development of targeted therapies for patients afflicted with ADSL deficiency. As recombinant protein technology continues to evolve, ongoing research aims to enhance our understanding of this critical enzyme, paving the way for novel diagnostic and therapeutic strategies.